These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 27070151)
1. The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan. Gosling R; von Seidlein L PLoS Med; 2016 Apr; 13(4):e1001994. PubMed ID: 27070151 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Asante KP; Abdulla S; Agnandji S; Lyimo J; Vekemans J; Soulanoudjingar S; Owusu R; Shomari M; Leach A; Jongert E; Salim N; Fernandes JF; Dosoo D; Chikawe M; Issifou S; Osei-Kwakye K; Lievens M; Paricek M; Möller T; Apanga S; Mwangoka G; Dubois MC; Madi T; Kwara E; Minja R; Hounkpatin AB; Boahen O; Kayan K; Adjei G; Chandramohan D; Carter T; Vansadia P; Sillman M; Savarese B; Loucq C; Lapierre D; Greenwood B; Cohen J; Kremsner P; Owusu-Agyei S; Tanner M; Lell B Lancet Infect Dis; 2011 Oct; 11(10):741-9. PubMed ID: 21782519 [TBL] [Abstract][Full Text] [Related]
3. Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa. Galactionova K; Tediosi F; Camponovo F; Smith TA; Gething PW; Penny MA Vaccine; 2017 Jan; 35(1):53-60. PubMed ID: 27890400 [TBL] [Abstract][Full Text] [Related]
4. RTS,S: Toward a first landmark on the Malaria Vaccine Technology Roadmap. Kaslow DC; Biernaux S Vaccine; 2015 Dec; 33(52):7425-32. PubMed ID: 26431982 [TBL] [Abstract][Full Text] [Related]
5. Simulating the impact of malaria vaccination: what has been learnt? Smith T; Tediosi F Expert Rev Vaccines; 2012 Jul; 11(7):751-3. PubMed ID: 22913250 [No Abstract] [Full Text] [Related]
6. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Bojang KA; Milligan PJ; Pinder M; Vigneron L; Alloueche A; Kester KE; Ballou WR; Conway DJ; Reece WH; Gothard P; Yamuah L; Delchambre M; Voss G; Greenwood BM; Hill A; McAdam KP; Tornieporth N; Cohen JD; Doherty T; Lancet; 2001 Dec; 358(9297):1927-34. PubMed ID: 11747915 [TBL] [Abstract][Full Text] [Related]
7. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models. Penny MA; Verity R; Bever CA; Sauboin C; Galactionova K; Flasche S; White MT; Wenger EA; Van de Velde N; Pemberton-Ross P; Griffin JT; Smith TA; Eckhoff PA; Muhib F; Jit M; Ghani AC Lancet; 2016 Jan; 387(10016):367-375. PubMed ID: 26549466 [TBL] [Abstract][Full Text] [Related]
8. Malaria vaccine: WHO position paper, January 2016 - Recommendations. World Health Organization Vaccine; 2018 Jun; 36(25):3576-3577. PubMed ID: 28385607 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the expanded program on immunization in sub-Saharan Africa: analysis of uncertainties using a stochastic individual-based simulation model of Plasmodium falciparum malaria. Maire N; Shillcutt SD; Walker DG; Tediosi F; Smith TA Value Health; 2011 Dec; 14(8):1028-38. PubMed ID: 22152171 [TBL] [Abstract][Full Text] [Related]
11. Could the RTS,S/AS01 meningitis safety signal really be a protective effect of rabies vaccine? Gessner BD; Knobel DL; Conan A; Finn A Vaccine; 2017 Feb; 35(5):716-721. PubMed ID: 28065475 [TBL] [Abstract][Full Text] [Related]
12. Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children. Olotu A; Fegan G; Wambua J; Nyangweso G; Leach A; Lievens M; Kaslow DC; Njuguna P; Marsh K; Bejon P N Engl J Med; 2016 Jun; 374(26):2519-29. PubMed ID: 27355532 [TBL] [Abstract][Full Text] [Related]
13. The RTS,S/AS01 malaria vaccine in children 5 to 17 months of age at first vaccination. Vandoolaeghe P; Schuerman L Expert Rev Vaccines; 2016 Dec; 15(12):1481-1493. PubMed ID: 27841689 [TBL] [Abstract][Full Text] [Related]
14. The malaria vaccine--status quo 2013. Heppner DG Travel Med Infect Dis; 2013; 11(1):2-7. PubMed ID: 23454205 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan. Mahmoudi S; Keshavarz H Hum Vaccin Immunother; 2017 Sep; 13(9):2098-2101. PubMed ID: 28272979 [TBL] [Abstract][Full Text] [Related]
17. The Advanced Development Pathway of the RTS,S/AS01 Vaccine. von Seidlein L Methods Mol Biol; 2019; 2013():177-187. PubMed ID: 31267502 [TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa. Otieno L; Guerra Mendoza Y; Adjei S; Agbenyega T; Agnandji ST; Aide P; Akoo P; Ansong D; Asante KP; Berkley JA; Gesase S; Hamel MJ; Hoffman I; Kaali S; Kamthunzi P; Kariuki S; Kremsner P; Lanaspa M; Lell B; Lievens M; Lusingu J; Malabeja A; Masoud NS; Mtoro AT; Njuguna P; Ofori-Anyinam O; Otieno GA; Otieno W; Owusu-Agyei S; Schuerman L; Sorgho H; Tanner M; Tinto H; Valea I; Vandoolaeghe P; Sacarlal J; Oneko M Vaccine; 2020 Jan; 38(4):897-906. PubMed ID: 31708182 [TBL] [Abstract][Full Text] [Related]
19. Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children. Lusingu J; Olotu A; Leach A; Lievens M; Vekemans J; Olivier A; Benns S; Olomi R; Msham S; Lang T; Gould J; Hallez K; Guerra Y; Njuguna P; Awuondo KO; Malabeja A; Abdul O; Gesase S; Dekker D; Malle L; Ismael S; Mturi N; Drakeley CJ; Savarese B; Villafana T; Ballou WR; Cohen J; Riley EM; Lemnge MM; Marsh K; Bejon P; von Seidlein L PLoS One; 2010 Nov; 5(11):e14090. PubMed ID: 21124768 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Alonso PL; Sacarlal J; Aponte JJ; Leach A; Macete E; Milman J; Mandomando I; Spiessens B; Guinovart C; Espasa M; Bassat Q; Aide P; Ofori-Anyinam O; Navia MM; Corachan S; Ceuppens M; Dubois MC; Demoitié MA; Dubovsky F; Menéndez C; Tornieporth N; Ballou WR; Thompson R; Cohen J Lancet; 2004 Oct 16-22; 364(9443):1411-20. PubMed ID: 15488216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]